 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
|---|---|
| Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
| ClinicalTrials.gov Identifier: | NCT00005131 |
Purpose
To measure associations of established and suspected coronary heart disease risk factors with both atherosclerosis and new coronary heart disease events in representative cohorts from four diverse United States communities. To compare the communities with respect to risk factors, medical care, atherosclerosis, and coronary heart disease incidence. ARIC has two components in each community: study of representative cohorts of adult men and women, and community surveillance of morbidity and mortality.
| Condition |
|---|
|
Atherosclerosis Coronary Disease Coronary Heart Disease Risk Reduction Diabetes Mellitus Cardiovascular Diseases Heart Diseases Heart Failure, Congestive Heart Failure |
Eligibility
No eligibility criteria
Contacts and Locations| Investigator: | Christie Ballantyne | Baylor College of Medicine |
| Investigator: | Lloyd Chambless | University of North Carolina |
| Investigator: | Josef Coresh | Johns Hopkins University |
| Investigator: | Matthew Davis | University of Wisconsin, Madison |
| Investigator: | Aaron Folsom | University of Minnesota |
| Investigator: | Gerardo Heiss | University of North Carolina |
| Investigator: | Daniel Jones | University of Mississippi Medical Center |
| Investigator: | Kenneth Wu | Texas Health Science Center |
More Information
